Blood pressure-lowering and risk of cancer: an individual participant-level data meta-analysis and Mendelian randomisation studies
NAZARZADEH LARZJAN M. et al, (2025), JACC: CardioOncology
blood pressure-lowering and risk of cancer: an individual participant-level data meta-analysis and mendelian randomisation studies
Nazarzadeh M. et al, (2024), European Heart Journal, 45
Refined selection of individuals for preventive cardiovascular disease treatment with a transformer-based risk model
Rao S. et al, (2024), European Heart Journal, 45
Blood pressure management in type 2 diabetes: a review of recent evidence.
Wamil M. et al, (2024), Heart
Polypill: a harmonious blend of stoicism and pragmatism in primary cardiovascular prevention.
Nazarzadeh M., (2024), Heart
Antihypertensive Treatment Evaluation in Multimorbidity and Polypharmacy Trial (ATEMPT): A decentralised open-label pilot trial
Majert J. et al, (2023), The Lancet. Healthy Longevity
Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-Analysis
Bidel Z. et al, (2023), Hypertension, 80, 2293 - 2302
The effect of immunomodulatory drugs on aortic stenosis: a Mendelian randomisation analysis.
Ciofani JL. et al, (2023), Sci Rep, 13
Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality.
Rao S. et al, (2023), Eur Heart J
Stratification of diabetes in the context of comorbidities, using representation learning and topological data analysis.
Wamil M. et al, (2023), Sci Rep, 13
The Effect of Immunomodulatory Drugs on Aortic Stenosis: A Mendelian Randomisation Analysis
Ciofani J. et al, (2023), Heart, Lung and Circulation, 32, S317 - S317
Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk.
Rao S. et al, (2023), Heart
ANTIHYPERTENSIVE TREATMENT EVALUATION IN A MULTIMORBIDITY AND POLYPHARMACY TRIAL (ATEMPT): A RANDOMISED CONTROLLED TRIAL
Rahimi K. et al, (2023), JOURNAL OF HYPERTENSION, 41, E13 - E13
Systolic Blood Pressure and Cardiovascular Risk in Patients With Diabetes: A Prospective Cohort Study.
Rao S. et al, (2022), Hypertension
High-Frequency Rheological and Piezo-Voltage Waveform Characterization of Inkjet-Printed Polymer-Based Dopant-Source Inks.
Hussain Z. et al, (2022), Micromachines (Basel), 14
Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes - Authors' reply.
Nazarzadeh M. et al, (2022), Lancet Diabetes Endocrinol, 10, 841 - 842
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
Nazarzadeh M. et al, (2022), The Lancet Diabetes & Endocrinology, 10, 645 - 654
Blood pressure and risk of venous thromboembolism: a cohort analysis of 5.5 million UK adults and Mendelian randomization studies.
Nazarzadeh M. et al, (2022), Cardiovasc Res